The “obesity first” approach in healthcare is gaining traction as clinicians focus on addressing obesity as the root cause of many chronic conditions, such as heart disease and diabetes. The advent of GLP-1 medications like Ozempic and Wegovy has shifted attention toward treating obesity directly, resulting in improvements in various health conditions. However, challenges remain, including access to affordable medications and potential long-term treatment implications.
Keep Reading
Add A Comment